NF1neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease)
Autism Reports / Total Reports
18 / 43Rare Variants / Common Variants
51 / 1Aliases
NF1, Neurofibromin, WSS, NFNS, VRNF, DKFZp686J1293Associated Syndromes
-Chromosome Band
17q11.2Associated Disorders
DD/NDD, ID, ASD, EPSGenetic Category
Rare Single Gene Mutation, Syndromic, Genetic Association, FunctionalRelevance to Autism
Neurofibromatosis is a Mendelian disease associated with autism. There is some association and linkage evidence implicating it in idiopathic autism, including positive association that was found with a NF1 polymorphism in the Japanese population (Marui et al., 2004). Chisholm et al., 2022 analyzed a study cohort of 68 children (3-15 years) with neurofibromatosis type I (NF1) who had scored above threshold on the Social Responsiveness Scale-Second Edition (T-score 60; 51% larger cohort) and completed the Autism Diagnostic Interview-Revised (ADI-R) and/or the Autism Diagnostic Observation Schedule-Second Edition (ADOS-2) and found that 63% met the ADOS-2 'autism spectrum' cut-off, while 34% exceeded the more stringent threshold for 'autistic disorder' on the ADI-R. Large-scale whole-exome and whole-genome seqeuncing studies have identified de novo variants in ASD probands from the Simons Simplex Collection, the Autism Sequencing Consortium, the MSSNG cohort, and the SPARK cohort (Sanders et al., 2012; Iossifov et al., 2014; Zhou et al., 2022). A two-stage analysis of rare de novo and inherited coding variants in 42,607 ASD cases, including 35,130 new cases from the SPARK cohort, in Zhou et al., 2022 identified NF1 as a gene reaching exome-wide significance (P < 2.5E-06).
Molecular Function
The encoded protein has Ras GTPase activity and appears to be a negative regulator of cell proliferation.
External Links
SFARI Genomic Platforms
Reports related to NF1 (43 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Negative Association | Association study of the NF1 gene and autistic disorder | Mbarek O , et al. (1999) | Yes | - |
2 | Negative Association | Lack of association of the (AAAT)6 allele of the GXAlu tetranucleotide repeat in intron 27b of the NF1 gene with autism | Plank SM , et al. (2001) | Yes | - |
3 | Highly Cited | Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1 | Costa RM , et al. (2002) | No | - |
4 | Primary | Association between the neurofibromatosis-1 (NF1) locus and autism in the Japanese population | Marui T , et al. (2004) | Yes | - |
5 | Recent Recommendation | Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells | Li F , et al. (2006) | No | - |
6 | Recent Recommendation | Neurofibromin regulation of ERK signaling modulates GABA release and learning | Cui Y , et al. (2008) | No | - |
7 | Recent Recommendation | Aberrant expression of synaptic plasticity-related genes in the NF1+/- mouse hippocampus | Park CS , et al. (2009) | No | - |
8 | Recent Recommendation | Behavioural and cognitive phenotypes in children with neurofibromatosis type 1 (NF1): the link with the neurobiological level | Hachon C , et al. (2010) | No | - |
9 | Highly Cited | The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins | Ballester R , et al. (1990) | No | - |
10 | Support | De novo mutations revealed by whole-exome sequencing are strongly associated with autism | Sanders SJ , et al. (2012) | Yes | - |
11 | Recent Recommendation | ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities | Wang Y , et al. (2012) | No | - |
12 | Recent Recommendation | Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study | Garg S , et al. (2012) | No | - |
13 | Support | A discovery resource of rare copy number variations in individuals with autism spectrum disorder | Prasad A , et al. (2013) | Yes | - |
14 | Support | Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations | Toma C , et al. (2013) | Yes | - |
15 | Recent Recommendation | Autism traits in the RASopathies | Adviento B , et al. (2013) | No | Autistic features |
16 | Recent Recommendation | Neurofibromatosis type 1 and autism spectrum disorder | Garg S , et al. (2013) | No | - |
17 | Support | The contribution of de novo coding mutations to autism spectrum disorder | Iossifov I et al. (2014) | Yes | - |
18 | Recent Recommendation | Prevalence of Autism Spectrum Disorder symptoms in children with neurofibromatosis type 1 | Plasschaert E , et al. (2014) | No | - |
19 | Support | Large-scale discovery of novel genetic causes of developmental disorders | Deciphering Developmental Disorders Study (2014) | No | - |
20 | Recent Recommendation | Cerebral volumetric abnormalities in Neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms | Huijbregts SC , et al. (2015) | No | - |
21 | Support | Clinical exome sequencing: results from 2819 samples reflecting 1000 families | Trujillano D , et al. (2016) | No | ASD |
22 | Support | High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies | Hamdan FF , et al. (2017) | No | DD/ID |
23 | Support | Early-onset epileptic encephalopathy and severe developmental delay in an association with de novo double mutations in NF1 and MAGEL2 | Akamine S , et al. (2018) | No | DD, epilepsy/seizures |
24 | Support | Targeted resequencing of 358 candidate genes for autism spectrum disorder in a Chinese cohort reveals diagnostic potential and genotype-phenotype correlations | Zhou WZ , et al. (2019) | Yes | - |
25 | Support | A novel RAB39B mutation and concurrent de novo NF1 mutation in a boy with neurofibromatosis type 1, intellectual disability, and autism: a case report | Santoro C et al. (2020) | No | ASD, ID, epilepsy/seizures |
26 | Support | - | Pode-Shakked B et al. (2021) | Yes | - |
27 | Support | - | Cummings K et al. (2022) | No | ASD |
28 | Support | - | Verberne EA et al. (2022) | No | - |
29 | Support | - | Chuan Z et al. (2022) | No | - |
30 | Support | - | Hu C et al. (2022) | Yes | - |
31 | Recent Recommendation | - | Zhou X et al. (2022) | Yes | - |
32 | Support | - | Chan AJS et al. (2022) | Yes | Neurofibromatosis type I |
33 | Support | - | Dyson A et al. (2022) | No | - |
34 | Support | - | Zhang Y et al. (2023) | Yes | ID, learning disability |
35 | Support | - | Santos S et al. (2023) | Yes | - |
36 | Support | - | Sheth F et al. (2023) | Yes | DD, ID |
37 | Support | - | Durkin J et al. (2023) | No | - |
38 | Support | - | Amerh S Alqahtani et al. (2023) | No | - |
39 | Support | - | Leonard D Kuhrt et al. (2023) | No | - |
40 | Support | - | Ruohao Wu et al. (2024) | No | - |
41 | Support | - | Axel Schmidt et al. (2024) | Yes | - |
42 | Support | - | Suhua Chang et al. () | Yes | - |
43 | Support | - | Karen Lob et al. () | Yes | ADHD, DD, ID, epilepsy/seizures |
Rare Variants (51)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
- | - | microsatellite | - | - | - | 11449390 | Plank SM , et al. (2001) | |
c.910C>T | p.Arg304Ter | stop_gained | De novo | - | - | 39136901 | Karen Lob et al. () | |
c.6365-2A>G | - | splice_site_variant | Unknown | - | - | 39136901 | Karen Lob et al. () | |
c.3496+2T>G | - | splice_site_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.7000-1G>C | - | splice_site_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.731-1G>T | - | splice_site_variant | Unknown | - | - | 35571021 | Chuan Z et al. (2022) | |
c.1246C>T | p.Arg416Ter | stop_gained | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.6792C>A | p.Tyr2264Ter | stop_gained | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.6930T>A | p.Pro2310%3D | stop_gained | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.7846C>T | p.Gln2616Ter | stop_gained | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.1885G>A | p.Gly629Arg | missense_variant | De novo | - | - | 35741772 | Hu C et al. (2022) | |
c.7395-2A>T | p.? | splice_site_variant | De novo | - | - | 37035742 | Zhang Y et al. (2023) | |
c.4772+1G>T | - | splice_site_variant | De novo | - | - | 29588991 | Akamine S , et al. (2018) | |
- | - | copy_number_loss | Familial | Maternal | Unknown | 23275889 | Prasad A , et al. (2013) | |
c.3610C>G | p.Arg1204Gly | missense_variant | De novo | - | - | 39136901 | Karen Lob et al. () | |
c.2684T>G | p.Met895Arg | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.4562T>G | p.Leu1521Arg | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.5794C>G | p.Leu1932Val | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.7163C>T | p.Thr2388Ile | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.8164C>G | p.Leu2722Val | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.4772+2T>C | - | splice_site_variant | De novo | - | Simplex | 35982159 | Zhou X et al. (2022) | |
c.7470C>T | p.Val2490%3D | synonymous_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.2041C>T | p.Arg681Ter | stop_gained | De novo | - | Simplex | 37543562 | Sheth F et al. (2023) | |
c.4207G>T | p.Ala1403Ser | splice_site_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.4267A>G | p.Lys1423Glu | missense_variant | Unknown | - | - | 35253369 | Verberne EA et al. (2022) | |
c.2585C>G | p.Thr862Ser | missense_variant | Unknown | - | - | 39039281 | Axel Schmidt et al. (2024) | |
c.3449C>G | p.Ser1150Ter | stop_gained | De novo | - | Simplex | 25363768 | Iossifov I et al. (2014) | |
c.6792C>G | p.Tyr2264Ter | stop_gained | De novo | - | Simplex | 29100083 | Hamdan FF , et al. (2017) | |
c.888+2T>G | - | splice_site_variant | De novo | - | Simplex | 34580403 | Pode-Shakked B et al. (2021) | |
c.6311T>C | p.Leu2104Pro | missense_variant | Familial | Maternal | - | 39136901 | Karen Lob et al. () | |
c.701del | p.Leu234ArgfsTer47 | frameshift_variant | Unknown | - | - | 35571021 | Chuan Z et al. (2022) | |
c.8188C>T | p.Leu2730Phe | missense_variant | Unknown | - | Simplex | 37543562 | Sheth F et al. (2023) | |
c.5327C>A | p.Ser1776Ter | stop_gained | De novo | - | Simplex | 27848944 | Trujillano D , et al. (2016) | |
c.4143C>T | p.Ile1381%3D | synonymous_variant | De novo | - | Multiplex | 35982159 | Zhou X et al. (2022) | |
c.3089C>T | p.Ser1030Leu | missense_variant | Familial | Paternal | - | 36309498 | Chan AJS et al. (2022) | |
c.7375C>A | p.His2459Asn | missense_variant | De novo | - | Simplex | 22495306 | Sanders SJ , et al. (2012) | |
c.107C>G | p.Thr36Ser | missense_variant | Familial | Maternal | - | 27848944 | Trujillano D , et al. (2016) | |
c.3938_3941del | p.Asp1313GlyfsTer13 | frameshift_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.7622_7623del | p.Gly2541AspfsTer14 | frameshift_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.653_654delinsT | p.Lys218MetfsTer7 | frameshift_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.276del | p.Lys92AsnfsTer11 | frameshift_variant | De novo | - | Simplex | 39126614 | Suhua Chang et al. () | |
c.6579+2T>C | - | splice_site_variant | De novo | - | Extended multiplex | 32873259 | Santoro C et al. (2020) | |
c.5754del | p.Asn1918LysfsTer7 | frameshift_variant | De novo | - | Simplex | 35982159 | Zhou X et al. (2022) | |
c.1742dup | p.Cys582LeufsTer6 | frameshift_variant | Familial | Maternal | - | 30763456 | Zhou WZ , et al. (2019) | |
c.2288T>C | p.Leu763Pro | missense_variant | Familial | Maternal | Simplex | 38764027 | Ruohao Wu et al. (2024) | |
c.7910G>A | p.Arg2637Gln | missense_variant | Familial | Paternal | Multiplex | 23999528 | Toma C , et al. (2013) | |
c.6938del | p.Gly2313ValfsTer12 | splice_site_variant | Familial | Maternal | - | 36309498 | Chan AJS et al. (2022) | |
c.3113+1G>A | - | splice_site_variant | Familial | Paternal | Multiplex | 37799141 | Amerh S Alqahtani et al. (2023) | |
c.7996_7997del | p.Asn2666HisfsTer26 | frameshift_variant | Familial | Maternal | - | 36309498 | Chan AJS et al. (2022) | |
c.499_502del | p.Cys167GlnfsTer10 | frameshift_variant | Familial | Paternal | Simplex | 36309498 | Chan AJS et al. (2022) | |
c.5425C>T | p.Pro1809Ser | missense_variant | De novo | - | Simplex | 25533962 | Deciphering Developmental Disorders Study (2014) |
Common Variants (1)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Paternal Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
N/A | N/A | microsatellite, intron_variant | - | - | - | 15389774 | Marui T , et al. (2004) |
SFARI Gene score
High Confidence, Syndromic
Score Delta: Score remained at 1S
criteria met
See SFARI Gene'scoring criteriaWe considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.
The syndromic category includes mutations that are associated with a substantial degree of increased risk and consistently linked to additional characteristics not required for an ASD diagnosis. If there is independent evidence implicating a gene in idiopathic ASD, it will be listed as "#S" (e.g., 2S, 3S, etc.). If there is no such independent evidence, the gene will be listed simply as "S."
7/1/2020
Score remained at 1
Description
Neurofibromatosis is a Mendelian disease associated with autism. There is some association and linkage evidence implicating it in idiopathic autism, including positive association that was found with a NF1 polymorphism in the Japanese population (Marui et al., 2004).
10/1/2019
Increased from S to 1
New Scoring Scheme
Description
Neurofibromatosis is a Mendelian disease associated with autism. There is some association and linkage evidence implicating it in idiopathic autism, including positive association that was found with a NF1 polymorphism in the Japanese population (Marui et al., 2004).
Reports Added
[New Scoring Scheme]1/1/2019
Increased from S to S
Description
Neurofibromatosis is a Mendelian disease associated with autism. There is some association and linkage evidence implicating it in idiopathic autism, including positive association that was found with a NF1 polymorphism in the Japanese population (Marui et al., 2004).
10/1/2017
Increased from S to S
Description
Neurofibromatosis is a Mendelian disease associated with autism. There is some association and linkage evidence implicating it in idiopathic autism, including positive association that was found with a NF1 polymorphism in the Japanese population (Marui et al., 2004).
10/1/2016
Increased from S to S
Description
Neurofibromatosis is a Mendelian disease associated with autism. There is some association and linkage evidence implicating it in idiopathic autism, including positive association that was found with a NF1 polymorphism in the Japanese population (Marui et al., 2004).
1/1/2016
Increased from S to S
Description
Neurofibromatosis is a Mendelian disease associated with autism. There is some association and linkage evidence implicating it in idiopathic autism, including positive association that was found with a NF1 polymorphism in the Japanese population (Marui et al., 2004).
Reports Added
[Association study of the NF1 gene and autistic disorder.1999] [Lack of association of the (AAAT)6 allele of the GXAlu tetranucleotide repeat in intron 27b of the NF1 gene with autism.2001] [De novo mutations revealed by whole-exome sequencing are strongly associated with autism.2012] [A discovery resource of rare copy number variations in individuals with autism spectrum disorder.2013] [Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations.2013] [Association between the neurofibromatosis-1 (NF1) locus and autism in the Japanese population.2004] [Autism traits in the RASopathies.2013] [Large-scale discovery of novel genetic causes of developmental disorders.2014] [The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.1990] [Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1.2002] [Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells.2006] [Neurofibromin regulation of ERK signaling modulates GABA release and learning.2008] [Aberrant expression of synaptic plasticity-related genes in the NF1 mouse hippocampus.2009] [Behavioural and cognitive phenotypes in children with neurofibromatosis type 1 (NF1): the link with the neurobiological level.2010] [ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.2012] [Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study.2012] [Neurofibromatosis type 1 and autism spectrum disorder.2013] [Prevalence of Autism Spectrum Disorder symptoms in children with neurofibromatosis type 1.2014] [Cerebral volumetric abnormalities in Neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunc...2015] [The contribution of de novo coding mutations to autism spectrum disorder2014]1/1/2015
Increased from S to S
Description
Neurofibromatosis is a Mendelian disease associated with autism. There is some association and linkage evidence implicating it in idiopathic autism, including positive association that was found with a NF1 polymorphism in the Japanese population (Marui et al., 2004).
10/1/2014
Increased from S to S
Description
Neurofibromatosis is a Mendelian disease associated with autism. There is some association and linkage evidence implicating it in idiopathic autism, including positive association that was found with a NF1 polymorphism in the Japanese population (Marui et al., 2004).
4/1/2014
Increased from No data to S
Description
Neurofibromatosis is a Mendelian disease associated with autism. There is some association and linkage evidence implicating it in idiopathic autism, including positive association that was found with a NF1 polymorphism in the Japanese population (Marui et al., 2004).
Reports Added
[Autism traits in the RASopathies.2013]Krishnan Probability Score
Score 0.60552752749814
Ranking 333/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.99999984557026
Ranking 210/18225 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.72227551621555
Ranking 1312/18665 scored genes
[Show Scoring Methodology]
Zhang D Score
Score -0.23470687392553
Ranking 16106/20870 scored genes
[Show Scoring Methodology]
CNVs associated with NF1(1 CNVs)
Sort By:
17q11.2 | 29 | Deletion-Duplication | 44 / 116 |
External PIN Data
Interactome
- Protein Binding
- DNA Binding
- RNA Binding
- Protein Modification
- Direct Regulation
- ASD-Linked Genes
Interaction Table
Interactor Symbol | Interactor Name | Interactor Organism | Interactor Type | Entrez ID | Uniprot ID |
---|---|---|---|---|---|
miR16 | microRNA mir-16 | Rat | RNA Binding | 100313997 | N/A |
TBPL1 | TBP-like 1 | Human | DNA Binding | 9519 | P62380 |
TNFSF13B | Tumor necrosis factor ligand superfamily member 13B | Human | Protein Binding | 10673 | Q9Y275 |
VSIG1 | V-set and immunoglobulin domain-containing protein 1 | Human | Protein Binding | 340547 | Q86XK7 |